Photo taken from C. Ola Landgren/X
Jul 4, 2024, 03:09
C. Ola Landgren: Highlights in Multiple Myeloma From ASCO and EHA 2024
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:
“Highlights in Multiple Myeloma From ASCO and EHA 2024. Lots of New Exciting Data. Great For Patients!”
Read further.
Source: C. Ola Landgren/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 10:18
Nov 19, 2024, 10:05
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28